Scientists Grab $11 Million to Study AstraZeneca PLC's Failed Drugs
British academic researchers have secured 7 million pounds ($11 million) of funding from the country's Medical Research Council (MRC) to investigate a range of potential new drugs made available free-of-charge by AstraZeneca.
The move is the latest example of how the pharmaceutical industry is experimenting with new research models involving greater collaboration with external partners.
The move is the latest example of how the pharmaceutical industry is experimenting with new research models involving greater collaboration with external partners.